Phycin leverages a unique algae-based platform, specifically utilizing the single-celled eukaryotic algae Chlamydomonas reinhardtii, to produce high-value recombinant growth factors. This innovative approach is rooted in over a decade of research and development, enabling the efficient expression of these proteins from both chloroplast and nuclear genomes. The resulting growth factors are not only cost-effective but also free from endotoxin and human pathogen contamination, making them suitable for a wide range of applications, including eye care, cell culture, and clean meat production. Phycin's proprietary technologies have demonstrated significant commercial potential, particularly in stem cell and tissue engineering, as evidenced by extensive experimental data.

In the realm of eye care, Phycin has developed groundbreaking therapies aimed at treating corneal injuries, which are prevalent among military personnel and the general public. Their algae-derived growth factors play a crucial role in enhancing cell culture media, promoting cellular processes essential for biomedical research and drug development. Additionally, Phycin's food-grade growth factors are pivotal in the clean meat industry, providing a safe and versatile solution for producing meat grown from cells outside of animals. This innovative technology addresses the challenges of production costs and safety, positioning Phycin as a leader in the evolution of clean meat and regenerative medicine.

United States

Discover Phycin's pioneering solution for ocular injuries – a groundbreaking therapy derived from the miraculous world of algae! As a leading innovator in growth factor technology, we present an unparalleled approach to transform the treatment of corneal damage for both military personnel and the general public. 

550 C Street West, Joint Base San Antonio-Randolph, Texas 78150-4727

Phycin

Phycin

Company Details